Pharmaceuticals and Biotech | Media Room

Press Release Nov 16, 2021

InDevR Launches ArrayMax Mixer for Even Faster VaxArray Assay Times

Press Release Nov 8, 2021

Swiss Life Sciences Group Opens Funding Platform for the CBD Industry

Swiss Life Sciences Group Plc (SLSG) has identified a need in the fast-growing cannabis and CBD industry to establish a financing and credit facility for companies and brands, especially those in the medical and pharmaceutical sector. Read More

Press Release Nov 4, 2021

Enalare Therapeutics Announces First Subject Dosed With Lead Product ENA-001 in a Propofol-Induced Respiratory Depression Study

Press Release Nov 2, 2021

Sambrosa, Manufacturer of Herbal-Based, Allergy Nighttime Syrup, Hosts New 'Sambrosa vs. Competitors' Challenge to Prove Their Reputation

Sambrosa is going head to head with competitors to uphold and defend their title of having the best allergy decongestant Read More

Press Release Nov 2, 2021

Enalare Therapeutics Invited to Present at BARDA Industry Day 2021

Press Release Nov 2, 2021

Philogen SpA - Notice of Q3 Results

Press Release Nov 1, 2021

Premier Pharmacy Services Adds UPLIZNA® (Inebilizumab-Cdon) to Rare Disease Portfolio

Press Release Nov 1, 2021

Gb Sciences Starts Preclinical Study for Plant-Based Formulas to Treat Depression and Anxiety

The biopharma technology company's AI-driven PhAROS™ platform has identified novel, plant-inspired formulations that will be tested using preclinical Zebrafish models at the National Research Council of Canada. Read More

Press Release Oct 26, 2021

RIVANNA announces award from U.S. government to develop Accuro Platform for rapid triage of blast-related injuries

Press Release Oct 26, 2021

Hyris Chalk Up Another Success Fighting COVID19, Providing Canadian Researchers and Medical Specialists With a New Test to Detect T-Cell Immune Response to SARS-CoV-2

Hyris developed a rapid T-Cell test to track patients' immunity levels to SARS-CoV-2 for global clinical and research use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the power of the renowned HYRIS bCUBE™ and the whole Hyris SystemTM. This disruptive platform enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform. Read More

Press Release Oct 20, 2021

BillionToOne's Senior Vice President of Sales and Commercial Operations Named One of the Top 25 Women Leaders in Biotechnology of 2021

Press Release Oct 14, 2021

Hyris Brings to Market Worldwide a New Test That Can Quickly Detect the Body's T-Cell Immune Response to SARS-CoV-2, Thanks to a Partnership With Singapore's Duke-NUS Medical

Hyris developed a rapid T-cell test to track patients' immunity levels to SARS-CoV-2 for global clinical use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the Hyris SystemTM, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform. Read More

Press Release Oct 13, 2021

Ethical Releases Zoom Connector for Endpoint Adjudication Meetings

The eAdjudication® electronic endpoint adjudication platform is upgraded with an innovative Zoom connector that allows it to streamline the management of endpoint adjudication meetings, and safely and conveniently file meeting recordings and transcriptions within the platform. Read More

Press Release Oct 9, 2021

Nuvi Global published scientific studies supporting that the all-natural supplement Stemforte Plus, helps release adult stem cells and activate telomerase activity

Press Release Oct 7, 2021

United Health Products Provides Business Update

Press Release Sep 30, 2021

Pro-ficiency Selected as Participant in DPharm Idol Disrupt

Pro-ficiency was selected as a participant in the DPharm Idol Disrupt program, hosted at the Disruptive Innovations conference September 28-29, 2021. Read More

Press Release Sep 28, 2021

OmeCare and LifeSite Announce COVID-19 Testing Solution Partnership

The partnership provides a turnkey approach for workplaces, schools, major conventions, and other group events looking to ensure safety and meet governmental mandates for students, staff, employees, and event participants. Read More

Press Release Sep 20, 2021

NEMA Research Inc. Named to Short-List of Citeline Awards for 2021 Nominated for Excellence in Innovation and Response to COVID-19

Press Release Sep 14, 2021

The Electronic Endpoint Adjudication Platform eAdjudication® Improves DICOM Images Central Reading and Adjudication With DICOM/PACS Integration

The new DICOM / PACS extension to the eAdjudication® electronic endpoint adjudication software brings on board the Orthanc server and a fully-equipped DICOM image viewer. This comprehensive solution facilitates the acquisition, storage, transmission and display of DICOM images for Expert Committees. Read More

Press Release Sep 14, 2021

The Hyris System™ Detects SARS-CoV-2, Including Recently Emerged Variants of Concerns.

As new mutations of SARS-CoV-2 keep spreading worldwide, Hyris keeps monitoring its test kits effectiveness, performing routine analysis of SARS-CoV-2 variants to safeguard public health and the product's quality by assessing the potential impact of new strains on sensitivity and specificity. Read More

Press Release Sep 9, 2021

Gb Sciences Presenting COVID-Related Cytokine Release Syndrome Results at H.C. Wainwright's 23rd Annual Global Investment Conference

Highlighting Gb Sciences' Development of Plant-Inspired Therapies for COVID-related Cytokine Release Syndrome, Chronic Pain, and Parkinson's Disease during the Healthcare & Biotech Track starting Monday, September 13. Read More

Press Release Sep 8, 2021

Proteintech Expands Collaboration With Epigenetics Company Active Motif

Press Release Sep 8, 2021

Royal Biologics Announces FDA Approval of the Maxx™ Concentration System.

Press Release Sep 7, 2021

LTO Network and Sphereon Partner With Triall for World's First Application of Blockchain Technology to COVID-19 Clinical Trials

Triall will use LTO Network's blockchain infrastructure to anchor COVID-19 research data, enhancing the safety, security and reliability of research data in the digital era. Read More

Press Release Sep 2, 2021

Polaryx Therapeutics Receives FDA Orphan Drug Designation for PLX-200 to Treat Krabbe Disease

Press Release Aug 30, 2021

New Report Finds 59 Drugs Have Been Recalled Due to Glass-Related Issues Since 2014

Press Release Aug 30, 2021

Epygenix Therapeutics Announces FDA Acceptance of IND to Initiate a Clinical Trial of EPX-100 to Treat Lennox-Gastaut Syndrome

Press Release Aug 30, 2021

Polaryx Therapeutics Announces FDA Grants Orphan Drug Designation for PLX-200 in GM2 Gangliosidoses

Press Release Aug 25, 2021

Enterin Announces Appointment of Hilde Williams as Senior Regulatory Advisor

Press Release Aug 23, 2021

Privo Technologies, Inc. Awarded $3M NIDCR NIH Commercialization Readiness Pilot Grant

Press Release Aug 23, 2021

Elixiron Immunotherapeutics Announces Closing of $27 Million Series A-1 Financing Round to Progress Alzheimer's Disease and Vitiligo Clinical-Stage Assets

Press Release Aug 19, 2021

Privo Technologies Named Winner of AIM-HI Accelerator Fund's Inaugural Women's Venture Competition

Press Release Aug 18, 2021

John Wainwright PhD Joins MIVI Neuroscience as Vice President, R&D

Press Release Aug 17, 2021

Woodward Pharma Services LLC Acquires LOVAZA® Capsules

Press Release Aug 17, 2021

Benchworks Named to Inc. 5000 List of America's Fastest-Growing Private Companies for Seventh Consecutive Year

Benchworks records three-year revenue growth rate of 75% to earn spot on esteemed list Read More

Press Release Aug 17, 2021

Royal Biologics Announces Partnership With Vilex Launching Its ALC Technology Into Lower Extremity Industry

Press Release Aug 17, 2021

Unique Approach Secures Access to Orphan Medication With a Complex PA for 68% of 'Unfillable' Prescriptions

Premier Pharmacy Services Releases New Case Study Regarding Complex Prior Authorizations Read More

Press Release Aug 16, 2021

ClinEdge & Skylight Health Expand Partnership

ClinEdge and Skylight Health Group expand their partnership to bring clinical trials to research sites in Colorado. Read More

Press Release Aug 11, 2021

Vanessa Ribreau Joins BenchSci as Chief People Officer to Lead Company's Embrace of the Future of Work

In the face of unprecedented workplace changes, senior HR leader will continue the evolution of BenchSci's progressive and award-winning culture Read More

Press Release Aug 10, 2021

New NCQA Program Highlights Specialty Pharmacies for Commitment to Quality

Specialty Pharmacy Accreditation Indicates Pharmacies' Readiness for Value-Based Contracts Read More

Press Release Aug 10, 2021

Enterin Announces Appointment of Alan Moses to Its Scientific Advisory Board

Press Release Aug 9, 2021

Amplity's Chief People Officer Named Delaware Valley Human Resources Person of the Year

The leading regional Human Resources (HR) organization celebrates Becky O'Loughlin as 2021's Chief Human Resources Officer (CHRO) of the Year Read More

Press Release Aug 4, 2021

SiO2 Materials Science Receives $64 Million Contract From U.S. Gov to Support Additional Scale Up of Advanced Primary Packaging Platform for Biological Drugs and Vaccines

Press Release Aug 4, 2021

Natural Hormone Replacement Therapy Paves New Path for Treatment at Nova Vita Wellness Centers

The plant-based pellets provide a customized alternative to conventional, synthetic HRT with each treatment tailored to the individual patient. Read More

Press Release Aug 4, 2021

Enalare Therapeutics Expands Its Scientific Team With Appointment of Thomas Miller, PhD, as Vice President of Clinical Development

Press Release Aug 3, 2021

SiO2 Materials Science Names Paul Fehlman as Chief Financial Officer

Mike Harrison to take on the role of Chief Accounting Officer and Treasurer Read More

Press Release Aug 3, 2021

ICE Global Consulting, Inc and Ledger Run, Inc Form Strategic Partnership

Press Release Aug 3, 2021

Ethisphere Leads APEC Effort to Measure the Impact of Doing Business With Integrity in the Asia Pacific Region

Research will explore the impact of a strong commitment to business integrity on small and medium-sized enterprise performance and resiliency through the pandemic Read More

Press Release Aug 2, 2021

GeneTex Develops Recombinant Influenza Nucleoprotein Antibodies as Potential Diagnostics

Press Release Aug 2, 2021

Health Canada Grants No Objection Letter to Epygenix Therapeutics to Proceed With ARGUS Trial for the Treatment of Dravet Syndrome

Press Release Aug 2, 2021

Epygenix Therapeutics Receives U.S. FDA Orphan Drug Designation for EPX-200 in Lennox-Gastaut Syndrome

Press Release Aug 2, 2021

Epygenix Therapeutics Receives Orphan Medicinal Product Designation in Europe With EPX-200 for the Treatment of Patients With Dravet Syndrome

Press Release Jul 29, 2021

'What the Health?': The Drug Price Dilemma

Ever Higher Rx Medication Prices Forcing Some Americans to Make Tough Choices Read More

Press Release Jul 28, 2021

Over 100 Validated Xenograft Models for IND Efficacy Testing. Preclinical GLP Research Services by Altogen Labs

Altogen Labs, biology CRO in Austin,Texas provides now 100+ in-house validated xenograft models for cancer research and IND Read More

Press Release Jul 28, 2021

OnePoint Patient Care to Open Pittsburgh, PA, Hospice-Dedicated Pharmacy

Press Release Jul 28, 2021

BenchSci Extends Impact on Drug Discovery With Addition of AI-Assisted Animal Model Selection

Addition of new product type to the BenchSci platform empowers scientists with relevant experimental evidence to accelerate novel medicine to clinical trials Read More

Press Release Jul 23, 2021

The Branford Group to Conduct Auction of Leading Genomic Testing Lab CQuentia in Memphis

Press Release Jul 21, 2021

Paramita Therapeutics, Inc. Awarded Competitive Grant From the National Science Foundation

Small Business Innovation Research Program Provides Seed Funding for R&D Read More

Press Release Jul 20, 2021

Direct Biologics Announces FDA Approval for Proceeding With Second ExoFlo IND for Post-Acute COVID-19 Syndrome and Chronic Post-COVID-19 Syndrome

Extracellular Vesicle Isolate Product ExoFlo Shows Strong Potential to Treat COVID-19, Post-Acute COVID-19 Syndrome, and Chronic Post-COVID-19 Syndrome; 60-patient trial to be conducted nationally at ambulatory infusion sites Read More

Press Release Jul 20, 2021

RxCelerate Establishes Venture Capital Division and Makes First Investment in US Metabolic Disease Company